X0607 3 2026-05-04 0 0001124105 GYRE THERAPEUTICS, INC. GYRE 0002133226 Wang Jialiang (NMN) false C/O GYRE THERAPEUTICS, INC. 12730 HIGH BLUFF DRIVE, SUITE 250 SAN DIEGO CA 92130 true EVP, General Manager Stock Option (Right to Buy) 0.32 2028-06-07 Common Stock 95060 D Stock Option (Right to Buy) 0.93 2030-01-12 Common Stock 38024 D Stock Option (Right to Buy) 2 2031-04-16 Common Stock 42777 D Stock Option (Right to Buy) 5.98 2034-11-12 Common Stock 47530 D This option is fully vested. This option represents a right to purchase 47,530 shares of the Issuer's common stock, one quarter of which vested on November 13, 2025, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date. Exhibit 24 - Power of Attorney /s/ Thomas Eastling, as attorney-in-fact for Jialiang Wang 2026-05-07